Search for: "Teva Pharmaceuticals"
Results 201 - 220
of 1,422
Sorted by Relevance
|
Sort by Date
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
10 Mar 2011, 3:18 pm
Teva Pharmaceuticals USA, Inc., Civ. [read post]
24 Mar 2009, 8:59 pm
Medicis' initial complaint, which was filed against Barr Pharmaceuticals (which has since been acquired by Teva) in January (see "Court Report," January 13, 2009), alleged infringement of U.S. [read post]
31 Dec 2015, 8:16 pm
• Defendants: Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
20 Oct 2014, 12:09 pm
On October 15, 2014, the Supreme Court heard oral argument inTeva Pharmaceuticals USA, Inc. v. [read post]
29 Aug 2016, 4:30 am
For example, Teva Pharmaceutical Industries has a competitive autoinjector. [read post]
21 Apr 2022, 3:26 pm
CVS Health Corp. and CVS Pharmacy Inc. will pay the state $484 million, while Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC over $134 million, and Endo Health Solutions $65 million. [read post]
23 Jul 2014, 4:00 am
Scott Gottlieb's post FDA's Looming Decision On A Generic To Teva's Copaxone Reveals Drug Approval Woes has a nice discussion of the issues facing the FDA on analyzing/approving generic Copaxone.Gottlieb stated:FDA is widely known to be considering the approval of a generic version of Teva Pharmaceutical’s (NYSE:TEVA) blockbuster drug for multiple sclerosis, Copaxone.The patents covering Copaxone for its 20mg/ml strength expired on May 24th. [read post]
10 Mar 2008, 9:54 pm
Noonan -- On Friday, the Court of Appeals for the Federal Circuit handed Pfizer a mixed decision on defendant Teva's appeal of a District Court judgment that Teva was liable for infringing a trio of Pfizer patents (U.S. [read post]
13 May 2009, 9:50 pm
After Defendant-Appellant Teva Pharmaceuticals USA, Inc. notified P&G of its intent to market a generic version of... [read post]
31 Mar 2014, 9:01 am
This morning the Supreme Court granted Teva’s petition for certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
15 May 2011, 8:55 pm
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
22 Jul 2010, 9:59 pm
By James DeGiulio -- Teva and Novartis Settle Patent Dispute over Zometa Teva Pharmaceuticals Industries Ltd. and Novartis Corp. have reached an agreement to settle their patent suit over a generic version of Zometa, a drug used to prevent skeletal fractures. [read post]
25 Oct 2017, 9:02 am
Switzerland was not part of the EU regulatory framework for the approval of pharmaceuticals. [read post]
26 Jan 2010, 9:59 pm
Teva Pharmaceuticals USA, Inc., Proctor & Gamble Co. v. [read post]
31 Mar 2014, 6:43 am
The Court has granted Teva Pharmaceuticals USA, Inc. v. [read post]
15 Oct 2014, 2:32 pm
The transcript in Teva Pharmaceuticals USA v. [read post]
6 May 2011, 3:00 am
Fox and Symons led Kirkland's team advising Teva Pharmaceuticals on its $6.8 billion acquisition of Cephalon, Inc. [read post]
7 Dec 2014, 9:03 pm
Teva Pharmaceuticals USA Inc. 1:14-cv-01451; filed December 2, 2014 in the District Court of Delaware • Plaintiffs: Reckitt Benckiser Pharmaceuticals Inc.; RB Pharmaceuticals Ltd.; MonoSol Rx LLC • Defendant: Teva Pharmaceuticals USA Inc. [read post]
16 Aug 2021, 2:15 pm
Court of Appeals for the Federal Circuit today issued two precedential decisions and one nonprecedential decision in cases involving Teva Pharmaceuticals and Eli Lilly, delivering wins and losses for each company. [read post]
